comparemela.com

Latest Breaking News On - Scientist group - Page 9 : comparemela.com

Measuring resilience to flooding and coastal change

Elasmogen announces a panel of novel, potent, anti-COVID-19 therapeutic candidates identified through collaboration with U S research partners

Share this article Share this article ABERDEEN, Scotland, Jan. 25, 2021 /PRNewswire/ Elasmogen Ltd, the pioneering biopharmaceutical company leading the development of VNAR and soloMER™ biologics, today announces a significant breakthrough in the identification of next-generation protein-based drugs potentially capable of stopping COVID-19 infections. This new approach has been achieved through a close partnership with the University of Minnesota, USA and represents an excellent example of the new spirit of research collaboration that has accelerated the global fight-back against COVID-19.  Initial funding for this work was received from the Chief Scientist Group, Scottish Government and was co-ordinated through the University of Aberdeen.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.